IOL Chemicals receives EDQM CEP certificate for Pantoprazole Sodium Sesquihydrate and Allopurinol
Drug Approval

IOL Chemicals receives EDQM CEP certificate for Pantoprazole Sodium Sesquihydrate and Allopurinol

EDQM has also issued a Certificate of Suitability for Allopurino

  • By IPP Bureau | June 12, 2024

European Directorate for the Quality of Medicines & Health Care (EDQM) has issued a Certificate of Suitability for "Pantoprazole Sodium Sesquihydrate" for alternative process (Process - II) on 10th June 2024. This certification will enable IOL Chemicals and Pharmaceuticals Limited to export this product in European and other CEP accepting countries. Pantoprazole is used for heartburn, acid reflux and gastro-oesophageal reflux disease (GORD). 

EDQM has also issued a Certificate of Suitability for Allopurinol. This certification will enable IOL Chemicals and Pharmaceuticals Ltd to export this product in European and other CEP accepting countries. Allopurinol is used to prevent increased uric acid, gout and joint pain.

Other Related stories

Startup

Digitization

India is becoming centre of innovation and global execution: Sanjay Vyas, President and MD, Parexel India
India is becoming centre of innovation and global execution: Sanjay Vyas, President and MD, Parexel India
Sanjay Vyas President and Managing Director, Parexel India And Global SBU Head- Safety services & Logistics, Parexel International